The present invention is directed to certain hydroxamate derivatives that are inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
CROSS REFERENCE
This application claims priority under 35 USC .sctn. 119(e) to U.S. provisional application Ser. No. 60/560,108, filed Apr. 7, 2004, the disclosure of which is incorporated herein by reference in its entirety.
